KLHDC4 and nasopharyngeal carcinoma: Similarly, KLHDC4 has been implicated in nasopharyngeal cancer by suppressing apoptosis, and CRISPR/Cas9 knockout of KLHDC4 has shown reduced tumour growth and migration [61], making it another potential therapeutic target, despite the lack of available inhibitors.